Southeast Asset Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Buy
12,698
+1,958
+18% +$226K 0.17% 83
2025
Q4
$1.13M Sell
10,740
-2,059
-16% -$193K 0.11% 99
2025
Q3
$1.07M Buy
12,799
+3,878
+43% +$319K 0.12% 99
2025
Q2
$706K Buy
8,921
+513
+6% +$40.8K 0.08% 106
2025
Q1
$755K Buy
8,408
+745
+10% +$69.6K 0.09% 102
2024
Q4
$762K Buy
7,663
+8
+0.1% +$825 0.09% 96
2024
Q3
$869K Buy
7,655
+6
+0.1% +$713 0.1% 93
2024
Q2
$947K Sell
7,649
-27
-0.4% -$3.48K 0.11% 87
2024
Q1
$1.01M Sell
7,676
-494
-6% -$60.9K 0.12% 86
2023
Q4
$891K Buy
8,170
+8
+0.1% +$830 0.12% 90
2023
Q3
$840K Sell
8,162
-527
-6% -$56.8K 0.12% 89
2023
Q2
$1M Buy
8,689
+7
+0.1% +$795 0.14% 72
2023
Q1
$924K Buy
8,682
+71
+0.8% +$7.67K 0.14% 75
2022
Q4
$955K Buy
8,611
+9
+0.1% +$920 0.15% 67
2022
Q3
$741K Buy
8,602
+42
+0.5% +$3.75K 0.13% 74
2022
Q2
$780K Buy
8,560
+8
+0.1% +$709 0.12% 85
2022
Q1
$702K Sell
8,552
-216
-2% -$17K 0.09% 98
2021
Q4
$672K Buy
8,768
+2,806
+47% +$223K 0.09% 96
2021
Q3
$448K Sell
5,962
-249
-4% -$18.9K 0.07% 100
2021
Q2
$483K Sell
6,211
-289
-4% -$21.5K 0.08% 99
2021
Q1
$478K Buy
6,500
+9
+0.1% +$664 0.09% 94
2020
Q4
$507K Buy
6,491
+7
+0.1% +$535 0.1% 93
2020
Q3
$513K Sell
6,484
-18
-0.3% -$1.41K 0.12% 86
2020
Q2
$480K Buy
6,502
+1,061
+20% +$79.9K 0.12% 85
2020
Q1
$399K Buy
5,441
+7
+0.1% +$550 0.12% 83
2019
Q4
$472K Buy
5,434
+6
+0.1% +$493 0.11% 83
2019
Q3
$436K Sell
5,428
-178
-3% -$14.3K 0.11% 87
2019
Q2
$449K Buy
5,606
+126
+2% +$9.65K 0.12% 80
2019
Q1
$435K Sell
5,480
-124
-2% -$9.27K 0.12% 83
2018
Q4
$409K Hold
5,604
0.12% 77
2018
Q3
$379K Hold
5,604
0.1% 86
2018
Q2
$325K Buy
5,604
+278
+5% +$15.7K 0.09% 89
2018
Q1
$277K Sell
5,326
-734
-12% -$39.6K 0.08% 94
2017
Q4
$325K Buy
6,060
+371
+7% +$20.6K 0.1% 94
2017
Q3
$348K Hold
5,689
0.11% 86
2017
Q2
$348K Buy
5,689
+110
+2% +$6.7K 0.11% 79
2017
Q1
$338K Sell
5,579
-2,086
-27% -$127K 0.11% 85
2016
Q4
$431K Buy
7,665
+15
+0.2% +$878 0.14% 75
2016
Q3
$456K Buy
7,650
+645
+9% +$37.7K 0.15% 72
2016
Q2
$385K Sell
7,005
-397
-5% -$21.1K 0.13% 80
2016
Q1
$374K Buy
7,402
+18
+0.2% +$882 0.12% 77
2015
Q4
$372K Buy
7,384
+2,842
+63% +$143K 0.13% 70
2015
Q3
$214K Hold
4,542
0.08% 79
2015
Q2
$247K Hold
4,542
0.09% 80
2015
Q1
$249K Hold
4,542
0.09% 76
2014
Q4
$246K Sell
4,542
-472
-9% -$26.3K 0.09% 82
2014
Q3
$284K Hold
5,014
0.11% 78
2014
Q2
$277K Buy
5,014
+210
+4% +$11.5K 0.1% 83
2014
Q1
$260K Sell
4,804
-1,289
-21% -$66.7K 0.1% 90
2013
Q4
$291K Sell
6,093
-472
-7% -$21.6K 0.11% 84
2013
Q3
$298K Hold
6,565
0.13% 76
2013
Q2
$291K Buy
+6,565
New +$293K 0.13% 65

Other funds holding MRK

Southeast Asset Advisors's MRK Position: Q1 2026 in Review

Southeast Asset Advisors increased its Merck (MRK) stake by 18% in Q1 2026, buying an estimated $226K and bringing the position to 12,698 shares worth $1.53M. The position accounts for 0.17% of the portfolio, ranked #83.

Southeast Asset Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Southeast Asset Advisors held 12,698 shares of Merck worth $1.53M as of Q1 2026.
  • Southeast Asset Advisors bought 1,958 Merck shares in Q1 2026, an estimated $226K.
  • Merck made up 0.17% of Southeast Asset Advisors's portfolio in Q1 2026, its #83 holding.
  • Southeast Asset Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Southeast Asset Advisors's 13F filing for Q1 2026, filed 13 May 2026.